Back to the main directory
EarningsReview / Equity
- Alibaba Health (241 HK) by HSBC
- Quantifying the pace of cost actions by BNP Paribas
- CLOsing the gaps one by one by BNP Paribas
- H126 results and 15 questions for management by BNP Paribas
- Non material data changes by BNP Paribas
- Let’s get digital by BNP Paribas
- Once bitten, twice shy by BNP Paribas
- House of Uncommons by BNP Paribas
- Great quality, but not as cheap as you think by BNP Paribas
- Reading global trends: modest signs of recovery by BNP Paribas
- DB1 - Allfunds: a potentially value accretive deal by BNP Paribas
- Decent debut but cost worries by BNP Paribas
- SMCP disposal process being restarted by BNP Paribas
- Short-term returns, long-term questions by BNP Paribas
- Steel Action Plan: Parliament draft points to minimal quota dilution by BNP Paribas
- Well prepared for the next growth chapter by BNP Paribas
- Ibersol - 3Q25 results: LfL acceleration, margin gains & healthy FCF by JB Capital Markets
- 3Q25 Quarterly Statement by BNP Paribas
- Airlines; mind the gap on fuel, US imports, Maersk, UK de minimis, Vinci/ Getlink, Eiffage, Airbus, UPS, IAG, Wizz Air by BNP Paribas
- European Spirits Data (Nielsen, Oct’25): Soft October volumes by BNP Paribas
- European Food/HPC data (Nielsen, Oct'25): Nestle/Henkel/L’Oreal improved, Lindt slower by BNP Paribas
- STEEL ACTION PLAN, MT, SZG, STEEL CANADA by BNP Paribas
- WE Soda ETS impacting Q4 trading; cautious on read across by BNP Paribas
- The Weekly Grocer featuring Milk Monitor by BNP Paribas
- GLP-1 tracker; are we back to “Here We-govy” time? by BNP Paribas